Allopurinol Plus Pentoxifilline in Hepatic Ischaemia/Reperfusion Injury  by Yildirim, Sadik et al.
ç ç
Allopurinol Plus Pentoxifilline in Hepatic Ischaemia/Reperfusion Injury
Sadik Yildirim, Hasan Tok, Hakan Köksal, Levent Erdem and Adil Baykan, Sisli Etfal Teaching State Hospital, Istanbul,
Turkey.
OBJECTIVES: Ischaemia/reperfusion injury of the liver is the major cause of liver dysfunction and
cellular death in transplantation and in liver resection with hepatic pedicle clamping. Many agents are
used to prevent this phenomenon, which occurs following interaction of different mediators during
both ischaemia and reperfusion. In this study, we aimed to assess the effects of allopurinol, a xanthine
oxidase inhibitor, and pentoxifilline, on liver ischaemia/reperfusion injury when used together and to
compare these with the effects of using these agents singly.
METHODS: Thirty-two rats were divided into four groups consisting of eight rats: Group C, control;
Group P, pentoxifilline; Group A, allopurinol; and Group PA, pentoxifilline + allopurinol. Alanine
aminotransferase (ALT), aspartate aminotransferase (AST), and lactate dehydrogenase (LDH) levels
were measured before hepatic pedicle clamping, on the 45th minute of ischaemia and 15 and 45 minutes
after reperfusion. Group P rats were injected with 50 mg/kg pentoxifilline, Group A rats 50 mg/kg
allopurinol and Group PA rats were injected with both agents 15 minutes before hepatic pedicle
clamping.
RESULTS: Ischaemia/reperfusion injury was produced by hepatic pedicle clamping, as demonstrated
by AST, ALT and LDH increase. Injury prevention occurred in Groups P, A and PA. No significantly
different (better) prevention was provided by giving allopurinol plus pentoxifilline to the rats.
Furthermore, no difference was observed between the allopurinol and pentoxifilline injected groups
in terms of preventing ischaemia/reperfusion injury.
CONCLUSIONS: Pretreatment with allopurinol or pentoxifilline resulted in significantly lower
hepatic enzyme elevation than that in controls in the rat liver ischaemia/reperfusion model. Using both
agents does not provide better protection than using either agent alone. (Asian J Surg 2002;25(2):149–53)
INTRODUCTION
Hepatic reperfusion injury following hepatic inflow
occlusion in major hepatic resection, liver transplantation
and in haemorrhagic shock, results in liver dysfunction
and cell death due to intracellular acidosis, activation of
autolytic systems, and mitochondrial dysfunction during
the reperfusion period.1–4 Free oxygen radicals, polymorph-
onuclear leucocytes and reactive oxygen metabolites
may be responsible for reperfusion injury.5 Free oxygen
radicals cause microvascular dysfunction and cell injury
leading to cell death and functional tissue injury by
induction of membrane lipid peroxidation, with the
reperfusion of ischaemic tissues in the intestine and liver. 6–8
Free oxygen radicals, especially superoxide and hydrogen
peroxide are produced in subcellular organelles (e.g.,
mitochondria) or in neutrophils by xanthine oxidase and
glucose oxidase enzymes.9 The main source of superoxide
radicals is xanthine oxidase, found as xanthine dehydrogenase
(Type-D) in healthy tissues (e.g., bowel, liver and lungs). In
reported series, free radicals are released 2 to 5 minutes
after reperfusion.10
The ability of exogenously administered superoxide
dismutase to prevent organ dysfunction and minimize
cell necrosis in some experimental models of ischaemia/
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reperfusion (I/R) injury demonstrates its role in this
pathological process.
Many agents are used with the aim of protecting tissue
from I/R injury. Pentoxifilline, a methyl xanthine derivative,
inhibits neutrophils and Kuppfer cell activation and
increases hepatic blood flow. Allopurinol, a xanthine
oxidase inhibitor, is also thought to decrease I/R injury in
some organs. In this study, we assessed the effects of these
agents on minimizing I/R injury in an experimental rat
liver I/R model. The results of administering the agents
alone, and in combination, were compared. As far as we
know, there is no available literature concerning the
allopurinol–pentoxifilline combination in preventing I/R
injury in the liver.
MATERIALS AND METHODS
Thirty-two female Sprague Dawley rats (200–280 g)
were assigned to four groups. After a 12-hour fast, all rats
were injected with 40 mg/kg of ketamine 15 minutes
before operation. After median laparotomy, the common
iliac vein was accessed via a 24G Angiocath for aspartate
aminotransferase (AST), alanine aminotransferase (ALT)
and lactate dehydrogenase (LDH) determination and drug
injection.
Table 1. Mean and standard deviation of AST, ALT and
LDH levels during the study
AST ALT LDH
C 451.2 ± 183.3 208.5 ± 57.6 3538.6 ± 2486.2
CI 1025.8 ± 350.5 536.6 ± 207.4 7057.5 ± 2675.6
C15 1644.6 ± 602.4 996.6 ± 132.5 10279.7 ± 2200.3
C45 4334.7 ± 1768.5 2065.2 ± 482.6 10779.4 ± 4236.3
PI 603.0 ± 207.1 322.2 ± 126.0 5205.6 ± 981.4
P15 749.5 ± 149.5 3581 ± 133.8 6348.0 ± 1154.3
P45 1125.6 ± 441.5 666.0 ± 305.3 8494.2 ± 2760.7
AI 838.7 ± 437.1 490.0 ± 413.4 4339.0 ± 1629.6
A15 928.7 ± 343.5 785.0 ± 345.0 5073.7 ± 1102.3
A45 980.5 ± 327.3 671.2 ± 321.9 6462.5 ± 1223.0
PAI 677.5 ± 289.7 267.1 ± 211.7 3837.6 ± 2240.9
PA15 853.3 ± 273.8 521.7 ± 330.6 5478.7 ± 2082.4
PA45 1085.7 ± 526.3 1063.5 ± 453.0 7861.2 ± 3035.0
AST = aspartate aminotransferase; ALT = alanine
aminotransferase; LDH = lactate dehydrogenase; C = control;
P = pentoxifilline; A = allopurinol; PA = pentoxifilline +
allopurinol; I = ischaemia; 15 = 15 minutes after reperfusion;
45 = 45 minutes after reperfusion.
In all groups, 0.5 ml of blood was drawn for biochemical
analysis. 0.5 ml 0.9% NaCl in water was injected into rats
in Group C; 50 mg/kg pentoxifilline diluted in 0.5 ml 0.9%
NaCl solution was administered to Group P; 50 mg/kg
allopurinol diluted in 0.5 ml 0.9% NaCl solution was
injected into Group A and 50 mg/kg pentoxifilline and
50 mg/kg allopurinol diluted in 0.5 ml 0.9% NaCl solution
were injected into rats in Group PA. After 15 minutes, the
hepatic pedicle (including the portal vein, hepatic artery
and bile duct) was occluded with a vascular clamp. After
45 minutes of ischaemia, 0.5 ml blood was drawn to
repeat the above biochemical tests. Perfusion was resumed
by clamp removal. Blood was assayed again 15 and
45 minutes after reperfusion.
Analysis of variance (ANOVA) for repeated measures
was used to assess enzyme level changes in individual
groups, and the ordinary ANOVA was used to compare
groups (p < 0.05 was deemed significant). The Tukey Kramer
test was used as post-test evaluation when p < 0.05.
RESULTS
Change within groups
Ischaemia
 In the P, A and PA groups, AST and ALT levels did not
increase significantly during the ischaemic period, while
LDH levels rose significantly in the control group.
Reperfusion
After 15 and 45 minutes of reperfusion, the three enzymes
were not increased significantly in the P, A and PA groups
but significantly increased in the control group (p < 0.05).
Comparison of groups
Ischaemia
No significant difference was observed in AST and
ALT levels between groups. LDH levels were significantly
higher in the control than in the A, P and PA groups.
Differences in LDH between the P, A, and PA groups were
not significant.
15 Minutes reperfusion
AST and ALT levels were significantly higher in the
control group than in the P, A and PA groups (p < 0.05) .
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LDH levels in controls were significantly increased from
that of P and PA groups but did not differ significantly from
the A group. No significant differences in the three enzyme
levels between the A, P and PA groups was observed.
45 minutes of reperfusion
All three enzymes were significantly increased in the
control group when compared with the P, A and PA
groups. There was no difference between the P, A and PA
groups (Figures 1, 2 and 3).
Figure 1. Aspartate aminotransferase (AST) levels: Repeated
values in each group are significantly different for the control
group (p < 0.01) and not significant between other groups.
(ANOVA  for repeated measures, p > 0.05). Comparison of
groups during ischaemia revealed no significant  difference. For
both periods of reperfusion, significant differences from control
were observed (p = 0.002 for R15 and p < 0.01 for R45).
Differences between P, A and PA groups were not significant
during the same periods (Tukey-Kramer post-test).
Figure 2. Alanine aminotransferase (ALT) levels: Repeated values
in each group were significantly different for the control group
(p < 0.01) and not significant between the other groups. (ANOVA
for repeated measures, p > 0.05). Comparison of groups during
ischaemia revealed no significant difference (p = 0.13). For both
periods of reperfusion, significant differences from the control
were observed (p < 0.01 for R15 and p < 0.01 for R45).
Differences between the P, A and PA groups were not significant
during same periods (Tukey-Kramer post-test).
Figure 3. Lactate dehydrogenase (LDH) levels: Repeated values
in each group were significantly different in all groups (ANOVA
for repeated measures, p < 0.05 ). Comparison of groups during
ischaemia revealed significantly high levels in the control group
(p = 0.026). Differences between the P, A and PA groups were
not significant (p = 0.6). P, A, and PA groups showed significant
differences from the  control during the R15  period (p < 0.01).
Comparison of P, A and PA groups revealed no significant
difference, whereas during R45, the difference between all
groups was insignificant (p = 0.08, ANOVA).
DISCUSSION
Reperfusion injury is an inevitable consequence of
ischaemia, produced iatrogenically during liver resection
or during organ preservation before transplantation surgery
or after prolonged hypovolaemic shock. Microcirculatory
disturbance seems to be involved in the mechanism of
I/R injury.11,12 The pathways implicated as causative of
injury to the microcirculation that occurs in this process
are multiple and complex. The cascades involved in the
mediation of I/R injury make it highly likely that effective
pharmacological modulation of the injury, leading to
prevention of ischaemic injury will depend on a
polypharmaceutical approach. In this study, we aimed to
use allopurinol plus pentoxifilline to provide a dual effect:
prevention of tissue injury during ischaemia by
pentoxifilline and prevention of injury during reperfusion
by allopurinol.
Hepatic vascular inflow obstruction in normothermic
I/R injury is characterized by raised AST, ALT and LDH
release, and these enzymes are well-recognized
biochemical markers of hepatic damage and are used to
determine I/R injury.13,14 Many agents and procedures
have been investigated to attempt to protect the liver from
I/R injury: calcium channel blockers, prostaglandins,
cytoprotective agents, steroids, vitamins, pentoxifilline,
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allopurinol and many others have been used for this
reason.15–18 These agents inhibit the production of free
radicals, or bind them, or enhance endogenous anti-
oxidant activity.
 Pentoxifilline is a methyl-xanthine derivative that
exhibits beneficial biological effects in sepsis, haemorrhage
or non-haemorrhagic ischaemia in various organs.19,20
The suggested mechanisms of protection include
vasodilation,21 increased flexibility of leucocytes,
erythrocytes and inhibition of platelet aggregation and
neutrophil infiltration.22–26 It also depresses inflammatory
cytokines,17 and prevents free radical formation via
inhibition of neutrophil or Kuppfer cell activation.27,28 In
the liver, pentoxifilline has been shown to increase hepatic
blood flow, surface oxygenation and restore hepato-
cellular function after haemorrhage or ischaemia.4,28
Allopurinol selectively blocks the production of free
radicals during reperfusion. Allopurinol and its primary
metabolite oxypurinol prevents the breakdown of
hypoxanthine into xanthine and uric acid by inhibiting
the xanthine oxidase. A plethora of theoretical and
experimental evidence suggests that allopurinol protects
various tissues from reperfusion injury following
ischaemia, 3,29–32 and University of Wisconsin solution
contains allopurinol.
In this study, we found that using both agents together
did not produce an additive effect. During ischaemia,
LDH levels were significantly increased in the control
group when compared with other groups (p = 0.02).
Preventive mechanisms other than those described above
could account for this difference. We found significantly
lower levels of AST, ALT and LDH enzyme levels in the A,
P and AP groups during both periods of reperfusion
(p < 0.05 vs control for each group). When all groups were
assessed with ordinary ANOVA, LDH levels were not
different after the 45 minutes of reperfusion (p = 0.08 ). No
difference was found when the A and P groups were
compared with the AP group during the same period. This
might be an error attributable to group size.
We conclude that allopurinol and pentoxifilline decrease
I/R injury produced by liver pedicle clamping, the degree of
injury being reflected by AST, ALT and LDH levels. Complete
protection cannot be provided by these agents. Pentoxifilline
and allopurinol prevent the rise of enzymes by a similar
degree, which may indicate similar levels of injury protection.
There seems to be no significant difference between their
effects. Using the two agents together revealed no additional
decrease in ALT, AST and LDH levels.
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